Tasly Biotech Annual Report Summary: Net profit attributable to the parent company in 2025 increased by 19.81% year-over-year

NightAirdropper · 2026-03-21T11:11:59+00:00

Radar Finance | Written by Feng Xiuyu | Edited by Li YihuiOn March 20, Tiens(300146) released its 2025 annual report summary. During the reporting period, operating revenue reached 6.265 billion yuan, a year-over-year decrease of 8.38%. Net profit attributable to shareholders of the listed company was 782 million yuan, a year-over-year increase of 19.81%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 686 million yuan, a year-over-year increase of 9.49%. Basic earnings per share was 0.47 yuan, a year-over-year increase of 20.51%.According to Tianyancha data, Tiens was established on April 1, 2005, with a registered capital of 1,700,845,431 yuan (RMB). The legal representative is Lin Zhicheng, and the registered address is No. 19 Xinghan Road, Sanzao Science and Technology Industrial Park, Jinwan District, Zhuhai City. The company's main business is the production and sales of dietary nutrition supplements.Currently, the company's chairman is Liang Yunchao, the board secretary is Tang Jinyin, and the number of employees is 28.

NightAirdropper

2026-03-21 11:11:59

Radar Finance | Feng Xiuyu (Writer) | Li Yihui (Editor)

On March 20th, Tasly Biotech (300146) released a summary of its 2025 annual report. During the reporting period, the company achieved operating revenue of 6.265 billion yuan, a decrease of 8.38% year-over-year. Net profit attributable to shareholders of the listed company was 782 million yuan, a 19.81% increase year-over-year. After excluding non-recurring gains and losses, net profit attributable to shareholders was 686 million yuan, up 9.49% year-over-year. Basic earnings per share were 0.47 yuan, an increase of 20.51%.

According to Tianyancha, Tasly Biotech was established on April 1, 2005, with a registered capital of 1,700,845,431 yuan. The legal representative is Lin Zhicheng, and the registered address is No. 19 Xinghan Road, Sanzhao Science and Technology Industrial Park, Jinwan District, Zhuhai. Its main business is the production and sale of dietary nutritional supplements.

Currently, the company’s chairman is Liang Yunchao, the secretary is Tang Jinyin, with 2,867 employees. The actual controller is Liang Yunchao.

The company has stakes in 56 subsidiaries, including PT PENTAVITE NUTRITION INDONESIA, Maiyou Network Technology (Zhuhai) Co., Ltd., Jianjin (Zhuhai Hengqin) E-commerce Co., Ltd., Infinite Energy Hanfang Pharmaceutical Co., Ltd., LIFE-SPACE HK LIMITED, and others.

In terms of performance, the company’s revenue for 2023, 2024, and 2025 was 9.407 billion yuan, 6.838 billion yuan, and 6.265 billion yuan, respectively, with year-over-year growth rates of 19.66%, -27.30%, and -8.38%. Net profit attributable to parent was 1.746 billion yuan, 653 million yuan, and 782 million yuan, with year-over-year growth rates of 26.01%, -62.62%, and 19.81%. During the same period, the company’s asset-liability ratio was 18.91%, 22.29%, and 19.95%.

Regarding risks, Tianyancha data shows the company has 174 internal Tianyan risks, 1,362 surrounding risks, 443 historical risks, and 469 early warning risks.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes